Amesite Inc. (AMST): auditor change — Amesite dismisses Deloitte as auditor, appoints Turner Stone; going concern emphasis in prior audit

Amesite Inc.

On Jan 27, 2023, Amesite dismissed Deloitte & Touche as its independent auditor and appointed Turner, Stone & Company.
Deloitte's FY2022 audit report contained an explanatory paragraph regarding uncertainty about Amesite's ability to continue as a going concern.
No disagreements on accounting principles occurred with Deloitte during FY2022 or FY2021.
Amesite previously disclosed material weaknesses in internal control over financial reporting as of June 30, 2022.
Turner Stone was not consulted on any accounting or audit matters prior to appointment.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Amesite Inc. dismissed Deloitte & Touche LLP as its auditor.

Action: dismissal
Auditor: Deloitte & Touche LLP

Exact text from the filing

On January 27, 2023, Amesite Inc. (the “Company”) dismissed Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Amesite Inc. engaged Turner, Stone & Company, L.L.P. as its auditor.

Action: engagement
Auditor: Turner, Stone & Company, L.L.P.

Exact text from the filing

On January 27, 2023, the Company appointed Turner, Stone & Company, L.L.P. (“Turner Stone”) as the Company’s new independent registered public accounting firm effective as of January 27, 2023.

View on SEC.gov

14 auditor changes filed in the last 30 days. Browse all auditor changes →

Amesite Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-007353

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.